Cover Image
Market Research Report

Needle Array Drug Delivery Systems: Devices, Therapeutic Markets, Strategies and Prospects

Published by Greystone Research Associates Product code 231900
Published Content info
Delivery time: 1-2 business days
Back to Top
Needle Array Drug Delivery Systems: Devices, Therapeutic Markets, Strategies and Prospects
Published: February 21, 2012 Content info:


Greystone Research Associates is pleased to announce the publication of a new market study. Needle Array Drug Delivery Systems: Devices, Therapeutic Markets, Strategies and Prospects is a comprehensive evaluation and analysis of the technology, devices, product development strategies and participants that comprise the needle array segment of the medical device sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, healthcare segments and commercial opportunities for needle arrays and devices in the delivery of therapeutic drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolving Materials Technology and Minimally Invasive Therapeutics

Evolution in drug delivery device design is changing the way a growing number of therapeutic substances are administered. This trend is being fostered by the desire by patients for more user friendly methods for self-medicating, and by the need for safer, more reliable drug products that improve compliance. For drugs designed to be delivered across the skin, needle arrays are viewed as an approach that addresses these key healthcare objectives.

Needle arrays offer several advantages when compared to conventional needle technologies including being minimally invasive due to their small cross-sectional area, providing precise penetration depth under the skin, inducing minimal trauma during insertion due to the advanced tip designs, and increased functionality. Important needle array fabrication technologies include micromachining, microforming, LIGA, and structured films. Prominent needle array form factors include solid (coated and uncoated) needle arrays, hollow needle arrays, dissolving needle arrays, programmable needle arrays, and phase transition needle arrays.

Needle array technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer a new class of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration.

Feature Summary

  • Provides assessments of marketed and development stage needle array drug delivery systems
  • Analyzes and evaluates needle array technology and product research & development activities, and assesses the medical market potential for existing and probable future products
  • Analyzes proprietary technologies and market development issues
  • Provides detailed descriptions of medical needle array drug delivery business opportunities, market demographics, and business strategies
  • Provides market data and forecasts to 2016
  • Profiles needle array product and technology participants, their activities, business strategies, and corporate alliances and affiliations
  • Evaluates the impact of economic, technology, and regulatory factors on the commercial potential of microneedle systems

Report Format and Availability

This report is available in electronic format. A site license for a single physical location and an Enterprise license are also available.


Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations. Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.

Table of Contents
Product Code: NAS858R

Table of Contents

Executive Summary

Active Transdermal Delivery Market Dynamics

  • Drug Classes, Indications and Demand
  • The Needle Array Ecosystem
  • What's Driving the Growth in Alternative Drug Delivery?
  • Competitive Landscape
  • Risk Factors

Needle Array Architecture, Technology & Fabrication

  • Needle Array Design Strategies
    • Solid Needle Arrays
    • Hollow Needle Arrays
    • Coated Needle Arrays
    • Dissolvable Needle Arrays
  • Needle Array Geometries &Form Factors
  • Needle Array Manufacturing
    • Material Selection Issues
    • Fabrication Techniques
    • Emerging Fabrication Methods

Needle Array Delivery Systems - Assessments & Commercial Prospects

  • Syringe-mounted Arrays
    • Micronjet
    • Nanoject
  • Solid Needle Arrays
    • sMTS
    • Macroflux
    • MicroCor
    • Micropatch
    • OnVax
    • Unbranded (Nanomed)
  • Hollow Needle Arrays
    • hMTS
    • Micro-Trans
    • Unbranded (MyLife Technologies)
  • Dissolvable Arrays
    • VaxMAT
    • Unbranded (BioSerenTach)
  • Metal Film Needle Arrays
    • AdminPatch
  • Phase Transition Needle Array Patches
    • Unbranded (BioPharm Solutions)
  • Programmable Needle Array Patch
    • Pyraderm
    • Unbranded (Janisys)
  • Spring Powered Needle Arrays
    • Unbranded (PKA SoftTouch)
  • Customizable Needle Arrays
    • Unbranded (Micropoint Technologies)

Near-Terms Markets for Needle Arrays - Assessments & Forecasts

  • Dermatology/Cosmetic Surgery
  • Diabetes
  • Genetic/DNA/Nucleotide Therapeutics
  • Oncology
  • Osteoporosis
  • Reproductive Medicine
  • Vaccines

Market Factors

  • Regulatory Considerations
  • Patient Preferences and Compliance
  • Managed Care Initiatives

Company Profiles

Back to Top